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Valorisation addendum 
 
This section addresses the impact and relevance of the studies described in 
this dissertation. Outlined are the way these studies are relevant to society, 
which target group can benefit, and how research findings have been 
disseminated. 
Societal relevance 
I would like to start this section by reconnecting with the background-section 
in Chapter 1 of this dissertation. Here, the prevalence of mental health related 
disorders was highlighted, and the implications it can have on the individual 
and society if left untreated. Moreover, it was highlighted that both 
conventional first-line treatments in Western societies for individuals affected 
by mood-related disorders (i.e CBT and SSRIs), appears to be less able to 
effectively resolve the disorder (Kuyken et al., 2005; Peter A Levine & 
Frederick, 1997; Moncrieff, 2007; Turner & Rosenthal, 2008). This implies 
that attempts to find a treatment to achieve full remission of mood-related 
disorders remains largely unsuccessful (Hengartner, 2017; Hengartner et al., 
2018; Moncrieff, 2007). Nevertheless, as the current dissertation 
demonstrates, psychedelic substances like ayahuasca and 5-MeO-DMT used 
in a naturalistic setting is associated with a decrease in symptoms of affect, 
an increase in mindfulness-related capacities, creativity, empathy and well-
being, moderated by the ratings of the psychedelic experience. The evidence 
of persisting positive effects on mood, wellbeing and cognition, following 
ayahuasca and 5-MeO-DMT ceremonies are crucial because impaired mood, 
deficits in mindfulness, as well as creative, flexible thinking, are hallmark 
symptoms in mood-related disorders such as depression, anxiety, and post-
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traumatic stress disorder (PTSD) (Samuel R Chamberlain, Naomi A 
Fineberg, Andrew D Blackwell, Trevor W Robbins, & Barbara J Sahakian, 
2006; A. M. Cusi, G. M. MacQueen, R. N. Spreng, & M. C. McKinnon, 2011; 
U.-S. Donges et al., 2005; Lee & Orsillo, 2014; Morrison et al., 2016; 
Gabriela Nietlisbach, Maercker, Rösler, & Haker, 2010; Palm & Follette, 
2011; Melissa Parlar et al., 2014).  
Moreover, findings reveal that the long-term improvements of mindfulness-
related capacities are not only limited to mindfulness-related practices such 
as meditation and yoga. Interestingly, increased mindfulness-related 
capacities could be beneficial in a therapeutic setting as it could prevent 
relapse in mood-related disorders (Breslin et al., 2002). Mindfulness has also 
shown to be a useful tool to develop emotion regulation skills (Linehan, 
1993), and can facilitate acceptance and change processes (Hayes & Wilson, 
2003; Strosahl & Wilson, 1999). Additionally, mindfulness is important for 
skill training in affective and interpersonal regulation prior to exposure 
(Cloitre et al., 2002). In sum, the use of mindfulness as an intervention for 
both post-traumatic stress disorder (PTSD), and addiction could 
theoretically break the behavioral loop in those individuals with a history of 
trauma and/or addiction (Cloitre et al., 2002).  
Additionally, previous research demonstrates that a reduction in creative and 
empathic skills in populations where social interactions and subjective well-
being are compromised. (A. T. Beck, 1967; Neumann et al., 2011). The 
enhancement of convergent thinking evoked post ayahuasca and 5-MeO-
DMT use could reverse this and help to improve people’s cognitive, 
emotional, and interpersonal capabilities. The enhancement of divergent 
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thinking is important in cognitive therapy as it can help strengthen 
psychological flexibility and adapt coping styles.  
How would a treatment for mood-related disorders with psychedelics look 
like? 
As per the introduction of this thesis (Chapter 1), although research points 
to both ketamine and psilocybin’s efficacy in treatment of mental health 
related disorders, there appears to be more to treatment but a stand-alone 
pharmacological intervention (i.e alternative pharmacotherapy). Therefore, 
psychedelics such as ayahuasca and 5-MeO-DMT could potentially be used 
in a therapeutic setting as catalysts to bring about betterment in mood-related 
symptoms as part of Psychedelic-assisted Psychotherapy (PAP) (Schenberg, 
2018). However, as we see per findings in Chapter 3, there are several non-
pharmacological factors to account for with ayahuasca, and that its effect on 
the mental health related variables seem to be a result of the synergy between 
pharmacology and the context rather than pharmacology alone. This may 
make it problematic to use ayahuasca in a PAP-setting, unless the context is 
specifically altered to include the various other factors that makes up the 
context of an “ayahuasca-setting”. However, as there are many ayahuasca 
ceremonies worldwide, and therefore many different contexts, there is exist 
not only one ayahuasca-setting but many. 5-MeO-DMT on the other hand is 
not tied up to any specific lineage or traditions. Consequently it may be easier 
to implement 5-MeO-DMT into a PAP setting similar to that outlined in the 
protocol for MDMA for PTSD (Mithoefer, Designee, Doblin, & Emerson, 
2008). Nevertheless, specific adjustments is advised to be made, and one can 
presume that those would largely depend on future assessments of 5-MeO-
DMT and the settings it shows to be effective in. It also appears that 
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regulations with regard to settings it is taken in is highly warranted due to the 
number of adverse effects associated with underground ceremonial settings 
("5-MeO-DMT malpractice; Open Letter Concerning Abuses by Octavio 
Rettig and Gerry Sandoval," 2019). Thus, its highly advised that 5-MeO-
DMT is used in a structured, such as for example a PAP-setting, where a 
therapist, or therapy team would meet with the patient prior to their trip to 
psychologically prepare them, monitors them throughout their trip, and then 
helps them process their experience afterwards (i.e., integration). 
Finally, as former research suggests, there are more targets besides the brain 
to focus on to bring about betterment in mood-related disorders. 
Consequently, it is strongly suggested that a novel treatment for mood-related 
disorders should not be developed yet as another a treatment or 
pharmacological intervention solely targeting the mind. Instead, there are 
reasons to believe that a holistic approach will be favorable. In fact, previous 
research on immunology, diet and brain-derived neurotrophic factor, and their 
connection with mood-related disorders demonstrate that the development 
and persisting symptoms of mood disorders appears to not to be the result of 
one process, but of a whole process. 
Target groups 
The findings discussed in this dissertation are relevant to multiple target 
groups. Firstly, the current findings are relevant to patients with various 
mood-related disorders. Secondly, the current findings are relevant for 
therapists working in the area of mental health. Thirdly, researchers in the 
field of psychedelics can use the knowledge of the present studies to base the 
design of placebo-controlled research on ayahuasca and 5-MeO-DMT. 
Moreover, the information in this dissertation can better guide other 
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researchers on how to go about their future research on psychedelics. 
Fourthly, the results of the studies summarized in this dissertation can inform 
organizations in the planning of potential clinical trials of ayahuasca and/or 
5-MeO-DMT. Finally, the current findings are also interesting to the general 
population and (potential) drug users who would like to be further informed 
about the psychedelic substances such as ayahuasca and 5-MeO-DMT.  
Dissemination and impact 
One of the goals of this thesis was to assess (persisting) effects of ayahuasca 
and 5-MeO-DMT in humans, and to further translate the findings into 
practical applications of the effects following ingestion. The author of this 
dissertation has taken various efforts to ensure that the knowledge gained 
from these studies are spread across different target groups. Moreover, the 
five studies summarized in this dissertation have been published in or 
submitted to several international peer-reviewed journal to share the findings 
with the international research community. Worthy of note is that the study 
described in Chapter 4, on the effect of toad secretion containing 5-MeO-
DMT on mental health related variables, was downloaded 120 000 times after 
its publication (information retrieved on the 14th of February 2020). In 
addition, most of the research findings have been presented at various 
international conferences; 
• September/October 2017 - the International Transpersonal Conference, 
Prague, The Czech Republic; poster presentation; “Acute and Long-term 
Effects of Ayahuasca on Affect and Cognitive Thinking style”. 
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• June 2018 - Beyond Psychedelic Conference in Prague, The Czech 
Republic – oral presentation: “In-vivo Effects of Toad Venom (5-MeO-
DMT) on Affect and Thinking Style”; 
https://slideslive.com/38908677/invivo-effects-of-toad-venom-
5meodmt-on-affect-andthinking-style 
• August 2019 – Breaking Convention 2019, in London, UK – oral 
presentation: “Prospective Examination of Synthetic 5-Methoxy-N,N-
dimethyltryptamine Inhalation: Effects on Salivary IL-6, Cortisol levels, 
Affect and Non-judgement“; 
https://www.youtube.com/watch?v=URSqxFocaas&t=373s 
• September 2019 – Insight Conference 2019, in Berlin, Germany – oral 
presentation: 
“The comparison of effects and experiences following either 
vaporization or intramuscular injection of synthetic 5-methoxy-N,N-
dimethyltryptamine in a naturalistic setting”; 
https://www.youtube.com/watch?v=opsWlr0MIu8&feature=share  
The research findings of various studies have also been discussed in 
podcasts and webinars. 
• March.2018 - Webinar for Emma Sofia about Ayahuasca and 5-MeO-
DMT, Oslo, Norway; 
https://www.youtube.com/watch?v=hTTurLoK_78 
• March 2018 - Psychedelics Today, USA – Podcast “Ayahuasca 
ceremonies and 5-MeO-DMT”; 
http://www.psychedelicstoday.com/2018/03/21/malin-vedoy-uthaug-
exploring-ayahuascaceremonies-and-5-meo-dmt/ 
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The future goal is to continue dissemination of the research findings through 
(inter)national journal publications, (inter)national conference visits, 
websites, in addition to the communication of research findings by means of 
workshops and public debates, presentations and podcasts in order to provide 
a more interactive atmosphere, and to help keep the scientific community as 
well as the general public informed and up to date about the topic. 
Finally, it is important to highlight that a collective multidisciplinary effort is 
necessary at a global level considering the many people that are suffering 
unnecessarily from mood-related disorders. A collaboration amongst 
scientists from different backgrounds and disciplines is highly warranted to 
determine further translational value of psychedelics, as well as ayahuasca 
and 5-MeO-DMT. Besides more science, a collective effort is warranted to 
bring about further education and information around the topic of 
psychedelics to the general public, and so too politicians to bring about de-
stigmatization, as well as policy change allowing for betterment in 
opportunities for the use of psychedelics in treatment of mood-related 
disorders. A way to go about such behavioral change on a societal level can 
perhaps be further investigated using Intervention Mapping (Bartholomew, 
Parcel, & Kok, 1998; Kok, Schaalma, Ruiter, Van Empelen, & Brug, 2004). 
 
 
 
 
 
 
